Cargando…

Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases

AIM: To investigate whether immune mediated diseases (IMD) are more frequent in patients with inflammatory bowel disease (IBD). METHODS: In this population based registry study, a total of 47325 patients with IBD were alive and registered in the Danish National Patient Registry on December 16, 2013....

Descripción completa

Detalles Bibliográficos
Autores principales:	Halling, Morten L, Kjeldsen, Jens, Knudsen, Torben, Nielsen, Jan, Hansen, Lars Koch
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597505/ https://www.ncbi.nlm.nih.gov/pubmed/28970729 http://dx.doi.org/10.3748/wjg.v23.i33.6137

Ejemplares similares

The IBD-FITT study — moderate-intensity exercise for patients with inflammatory bowel disease with moderate disease activity: an open-label randomized controlled trial
por: Lund, Ken, et al.
Publicado: (2023)

Role of telomere shortening in anticipation of inflammatory bowel disease
por: Truta, Brindusa, et al.
Publicado: (2020)

Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study
por: Choi, You-Jung, et al.
Publicado: (2019)

Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease
por: Ma, Hai-Qin, et al.
Publicado: (2018)

Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease
por: Horvat, Natally, et al.
Publicado: (2016)

Frequency, types, and treatment of anemia in Turkish patients with inflammatory bowel disease
por: Bengi, Göksel, et al.
Publicado: (2018)

Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease
por: Gordon, Benjamin Langan, et al.
Publicado: (2022)

Major depressive disorders in patients with inflammatory bowel disease and rheumatoid arthritis
por: Haider, Maryam Bilal, et al.
Publicado: (2023)

Essential role of small bowel capsule endoscopy in reclassification of colonic inflammatory bowel disease type unclassified
por: Monteiro, Sara, et al.
Publicado: (2017)

Valuable clinical indicators for identifying infantile-onset inflammatory bowel disease patients with monogenic diseases
por: Su, Wen, et al.
Publicado: (2021)

Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting
por: Berkowitz, Joshua C, et al.
Publicado: (2018)

High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients
por: Girardin, Marc, et al.
Publicado: (2018)

Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective
por: Pallav, Kumar, et al.
Publicado: (2017)

Physical activity measured by accelerometry in paediatric and young adult patients with inflammatory bowel disease
por: Lund, Ken, et al.
Publicado: (2022)

Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study
por: Lee, Jooyoung, et al.
Publicado: (2019)

Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease
por: Bajer, Lukas, et al.
Publicado: (2018)

Childhood-onset inflammatory bowel diseases associated with mutation of Wiskott-Aldrich syndrome protein gene
por: Ohya, Takashi, et al.
Publicado: (2017)

Prevalence, phenotype and medication for the pediatric inflammatory bowel disease population of a state in Southeastern Brazil
por: Martins, Adalberta Lima, et al.
Publicado: (2022)

Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study
por: Park, Seona, et al.
Publicado: (2018)

Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis
por: Hoffmann, Peter, et al.
Publicado: (2020)

Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
por: Lew, Daniel, et al.
Publicado: (2017)

Serological investigation of IgG and IgE antibodies against food antigens in patients with inflammatory bowel disease
por: Wang, Hai-Yang, et al.
Publicado: (2019)

Apolipoprotein E variants correlate with the clinical presentation of paediatric inflammatory bowel disease: A cross-sectional study
por: Glapa-Nowak, Aleksandra, et al.
Publicado: (2021)

Positive correlation between latent Epstein-Barr virus infection and severity of illness in inflammatory bowel disease patients
por: Wei, Hong-Tao, et al.
Publicado: (2023)

Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease
por: Rubio, Marrieth G, et al.
Publicado: (2019)

Bowel inflammatory presentations on computed tomography in adult patients with severe aplastic anemia during flared inflammatory episodes
por: Zhao, Xi-Chen, et al.
Publicado: (2023)

Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy
por: Rubin, Samuel J S, et al.
Publicado: (2022)

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease
por: Spekhorst, Lieke M, et al.
Publicado: (2017)

Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease
por: Yao, Ling-Ya, et al.
Publicado: (2022)

Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification
por: Lopez-Siles, Mireia, et al.
Publicado: (2020)

Hospital costs, length of stay and prevalence of hip and knee arthroplasty in patients with inflammatory bowel disease
por: Ehrenpreis, Eli D, et al.
Publicado: (2017)

Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability
por: Bohra, Anuj, et al.
Publicado: (2020)

Regional variation of pediatric inflammatory bowel disease in Saudi Arabia: Results from a multicenter study
por: El Mouzan, Mohammad I, et al.
Publicado: (2020)

Active tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin America
por: Fortes, Flora Maria Lorenzo, et al.
Publicado: (2020)

Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study
por: Hahn, Gustavo Drügg, et al.
Publicado: (2022)

Efficacy of ileus tube combined with meglumine diatrizoate in treating postoperative inflammatory bowel obstruction after surgery
por: Yang, Wen, et al.
Publicado: (2023)

Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease
por: Kostas, Athanasios, et al.
Publicado: (2017)

Epidemiological characteristics of Asian children with inflammatory bowel disease at diagnosis: Insights from an Asian-Pacific multi-centre registry network
por: Huang, James Guoxian, et al.
Publicado: (2022)

Vaccination coverage in children with juvenile idiopathic arthritis, inflammatory bowel diseases, and healthy peers: Cross-sectional electronic survey data
por: Makarova, Elizaveta, et al.
Publicado: (2023)

Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark
por: Kjeldsen, Jens, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c513o9r1ca8h38dopkkcp6krgq